Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
<h4>Background</h4>Following one to five years of antibiotic mass drug administration (MDA) for the elimination of trachoma as a public health problem, programmes must conduct impact surveys to inform decisions on whether MDA is still needed. These decisions are currently based on the pr...
Saved in:
Main Authors: | Sarah E Burr (Author), John Hart (Author), Lyson Samikwa (Author), David Chaima (Author), Gretchen Cooley (Author), Diana Martin (Author), Michael Masika (Author), Anthony W Solomon (Author), Robin L Bailey (Author), Khumbo Kalua (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.
by: Anaseini Cama, et al.
Published: (2017) -
Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.
by: Victor H Hu, et al.
Published: (2013) -
Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
by: Anna R Last, et al.
Published: (2014) -
Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania.
by: Xinyi Chen, et al.
Published: (2022) -
Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
by: Emma M Harding-Esch, et al.
Published: (2009)